Synopsis
Localise malabsorption to luminal digestion, intestinal mucosa, bile acid handling, lymphatic transport or reduced absorptive surface; test for coeliac disease and pancreatic insufficiency correctly; and replace deficits without obscuring the cause.
- Steatorrhoea, chronic diarrhoea, weight loss, bloating, anaemia, oedema, bruising, neuropathy or bone disease may be the presenting phenotype; absence of obvious stool fat does not exclude malabsorption.
- Classify mechanisms: impaired intraluminal digestion, mucosal disease, reduced small-bowel surface, bile acid diarrhoea, lymphatic obstruction or mixed postoperative causes.
- For coeliac testing, the patient must be eating gluten; check total IgA with IgA tissue transglutaminase and use appropriate IgG-based testing in IgA deficiency.
Key red flags
Steatorrhoea, weight loss, diabetes, recurrent pancreatitis, pancreatic surgery or chronic epigastric pain suggests inadequate enzyme delivery; pancreatic cancer must be considered with new symptoms or jaundice.
Investigation priorities
Measure total IgA and IgA tTG, with EMA for weakly positive results and IgG-based testing when IgA deficient according to the current pathway.
Management branches
Chronic diarrhoea, steatorrhoea, weight loss or unexplained nutrient deficiency suggests impaired absorption.
- Confirm stool and weight phenotype, review diet, surgery, pancreas, ileum, medicines, travel and immune state, and assess dehydration or severe deficiency.
- Screen for coeliac disease while gluten is still consumed, inflammation and common deficiencies; add faecal elastase and bile acid testing according to phenotype.